Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico

Introduction: Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccines (PCV13) since their inclusion in the National Immunization Program (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasserman, Matthew, Palacios, Maria Gabriela, Grajales, Ana Gabriela, Baez/Revueltas, F. Berenice, Wilson, Michele, McDade, Cheryl, Farkouh, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605727/
https://www.ncbi.nlm.nih.gov/pubmed/30156978
http://dx.doi.org/10.1080/21645515.2018.1516491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605727/
https://www.ncbi.nlm.nih.gov/pubmed/30156978
http://dx.doi.org/10.1080/21645515.2018.1516491

Ejemplares similares